Merck v. Integra Lifesciences

Case Number: CLB0077

Date: 06.13.2005

Preclinical research that is not included in an FDA submission can be exempt from patent infringement under 35 U.S.C. § 271(e)(1) if the drug maker has a reasonable basis for believing that the research, if successful, would be appropriate to include in an FDA submission.

Download PDF Return to Case Law Briefs Main Page